Telomeres are an aging clock
- Telomeres are the protective caps of our DNA
- Telomeres shorten over time
- When telomeres become too short, our cells can't function
- This is a major cause of aging
Our breakthrough drug
- Messenger RNA encoding telomerase (TERT mRNA)
- One dose reverses years of telomere shortening in days
- Invented by the founders while at Stanford University
- Works in vivo
Pipeline
We have a robust pipeline focused on aging and fatal diseases in which short telomeres have causal or major exacerbating roles. We are developing these programs in-house and through partnerships and out-licensing.
Team
Our strategy is to make safe rapid telomere extension available as broadly and quickly as possible
John Ramunas
Founder & CEO, Stanford PhD, Co-inventor, Decade of experience with mRNA for therapeutic applications. Thesis title: Telomere extension to extend human healthspan.
Glenn Markov
Founder & COO, Stanford PhD, Decade of experience in genetics and epigenetics of cellular reprogramming.
Will Olsen
VP of Development Operations, Founder of liver diagnostics company, Luminist (acquired by DiscernDx). Decade of drug and device development experience.
Helen M. Blau
Founder & Advisor, Co-inventor, Professor at Stanford University, discovered that short telomeres underlie the fatal etiology of multiple monogenic diseases.
Apoorva Shankar
Life Science Research Associate, MSc in Biotechnology.
Kyle Brewer
Research Scientist, Postdoc at Stanford University on the proteomics of aging in the liver and brain, PhD in Biophysics at UT Southwestern on neurotransmitter release.
Bo Yang
Research Fellow, MD, MSc, PhD, CTBS, Clinical and Preclinical Development at Boehringer Ingelheim and Gilead. Postdoc at Yale University on novel roles of ion transport proteins.
Robin E. Holbrook
Director of Finance and Administration, Stanford AB in Cultural Anthropology, 30+ years of F&A experience supporting research excellence at Stanford School of Medicine.
Contact Us
Patient inquiries: patients@rejuvenationtech.com
General inquiries: info@rejuvenationtech.com
Employment inquiries: jobs@rejuvenationtech.com
Investor inquiries: investors@rejuvenationtech.com
Rejuvenation Technologies also provides our TeloAid line of reagents and nucleic acid compounds for use in scientific and medical research. Please contact sales@rejuvenationtech.com for orders meeting your specifications and needs.
